By Deron Hamel TORONTO – This year’s Epilepsy Action Day successfully sent a message to Ontario’s MPPs and policy makers that “epilepsy matters and people with epilepsy matter,” says Paul Raymond, Epilepsy Ontario’s executive director. About 30 people representing epilepsy agencies across Ontario were at Queen’s Park on Oct. 27 for Epilepsy Action Day, an…
By Deron Hamel Enhanced confidence, independence and making friends – these are the main benefits Philippa Howell says her daughter, Georgina, has garnered since she started attending Summerfest Camp five years ago. Georgina, 13, is living with intractable myoclonic epilepsy as well as autism. She has been attending the camp since she was eight. In…
By Deron Hamel A 2,000-per-cent price hike on a medication to treat infantile spasms is “predatory behaviour” on the part of Questcor Pharmaceuticals, and drug companies could hike prices on other seizure medications if policies aren’t put into place, says pediatric neurologist Dr. Carter Snead. Infantile spasms – also called West syndrome – is a…
By Deron Hamel A World Health Organization (WHO) resolution that was unanimously passed earlier this year could create large-scale, positive change in epilepsy treatment across the globe, says Mary Secco, an Ontario advocate for people with epilepsy. Secco, who is co-chair of the International League Against Epilepsy’s (ILAE’s) Global Outreach Task Force as well as…
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
